Marrazzo Jeffrey D 4
4 · Prime Medicine, Inc. · Filed May 19, 2025
Insider Transaction Report
Form 4
Marrazzo Jeffrey D
Director
Transactions
- Award
Stock Option (right to buy)
2025-05-19+800,000→ 800,000 totalExercise: $1.33→ Common Stock (800,000 underlying)
Footnotes (1)
- [F1]500,000 of the shares underlying this option shall vest and become exercisable in twenty-four (24) equal monthly installments over a two-year period commencing from May 19, 2025; 300,000 of the shares underlying this option shall vest and become exercisable in three equal installments based on the Issuer's satisfaction of certain performance criteria tied to stock price, in each case subject to the Reporting Person's continued service on each such vesting date.